540 related articles for article (PubMed ID: 27818234)
21. Effects of interferon therapy in "non responder" patients with chronic hepatitis C.
Poynard T; Moussali J; Ratziu V; Regimbeau C; Opolon P
J Hepatol; 1999; 31 Suppl 1():178-83. PubMed ID: 10622583
[TBL] [Abstract][Full Text] [Related]
22. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis.
Tanaka K; Sakai H; Hashizume M; Hirohata T
Jpn J Cancer Res; 1998 Dec; 89(12):1241-50. PubMed ID: 10081484
[TBL] [Abstract][Full Text] [Related]
23. VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response.
Matono T; Tada T; Nishimura T; Takashima T; Aizawa N; Ikeda N; Shiomi H; Enomoto H; Iijima H
J Med Ultrason (2001); 2024 Apr; 51(2):293-300. PubMed ID: 38147196
[TBL] [Abstract][Full Text] [Related]
24. Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
Forouzannia F; Hamadeh A; Passos-Castilho AM; Erman A; Yu A; Feng Z; Janjua NZ; Sander B; Greenaway C; Wong WWL
Liver Int; 2024 Jun; 44(6):1383-1395. PubMed ID: 38445848
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
[TBL] [Abstract][Full Text] [Related]
26. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Lee MH; Chen YT; Huang YH; Lu SN; Yang TH; Huang JF; Yin SC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Yang HI; Chen HY; Chen CJ
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1275-1285.e2. PubMed ID: 38365094
[TBL] [Abstract][Full Text] [Related]
27. Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma.
Poynard T; Moussalli J; Ratziu V; Regimbeau C; Opolon P
Clin Liver Dis; 1999 Nov; 3(4):869-81. PubMed ID: 11291256
[TBL] [Abstract][Full Text] [Related]
28. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
[TBL] [Abstract][Full Text] [Related]
29. Comparison of postoperative outcomes in cases achieving sustained virological response with direct-acting antiviral and interferon therapy.
Hashimoto M; Kobayashi T; Ohira M; Okimoto S; Abe T; Inoue M; Onoe T; Honmyo N; Kuroda S; Ohdan H
J Hepatobiliary Pancreat Sci; 2024 May; 31(5):318-328. PubMed ID: 38135908
[TBL] [Abstract][Full Text] [Related]
30. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Sacco M; Ribaldone DG; Saracco GM
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140692
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study.
Dutta U; Byth K; Kench J; Khan MH; Coverdale SA; Weltman M; Lin R; Liddle C; Farrell GC
Aust N Z J Med; 1999 Jun; 29(3):300-7. PubMed ID: 10868491
[TBL] [Abstract][Full Text] [Related]
32. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Reddy KR; McLerran D; Marsh T; Parikh N; Roberts LR; Schwartz M; Nguyen MH; Befeler A; Page-Lester S; Tang R; Srivastava S; Rinaudo JA; Feng Z; Marrero JA
Gastroenterology; 2023 Oct; 165(4):1053-1063.e6. PubMed ID: 37429366
[TBL] [Abstract][Full Text] [Related]
33. Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Hamill V; Gelson W; MacDonald D; Richardson P; Ryder SD; Aldersley M; McPherson S; Verma S; Sharma R; Hutchinson S; Benselin J; Barnes E; Guha IN; Irving WL; Innes H
Liver Int; 2023 Apr; 43(4):917-927. PubMed ID: 36708150
[TBL] [Abstract][Full Text] [Related]
34. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.
Imai Y; Kawata S; Tamura S; Yabuuchi I; Noda S; Inada M; Maeda Y; Shirai Y; Fukuzaki T; Kaji I; Ishikawa H; Matsuda Y; Nishikawa M; Seki K; Matsuzawa Y
Ann Intern Med; 1998 Jul; 129(2):94-9. PubMed ID: 9669992
[TBL] [Abstract][Full Text] [Related]
35. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.
Cammà C; Giunta M; Andreone P; Craxì A
J Hepatol; 2001 Apr; 34(4):593-602. PubMed ID: 11394661
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection in alcoholic liver cirrhosis in Japan: its contribution to the development of hepatocellular carcinoma.
Miyakawa H; Sato C; Izumi N; Tazawa J; Ebata A; Hattori K; Sakai H; Ikeda T; Hirata R; Sakai Y
Alcohol Alcohol Suppl; 1993; 1A():85-90. PubMed ID: 8141927
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients.
Kuwana K; Ichida T; Kamimura T; Ohkoshi S; Ogata N; Harada T; Endoh K; Asakura H
J Gastroenterol Hepatol; 1997 Feb; 12(2):149-55. PubMed ID: 9083916
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws?
Farrell GC
J Gastroenterol Hepatol; 1999 Sep; 14(9):833-7. PubMed ID: 10535462
[No Abstract] [Full Text] [Related]
39. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.
Schöniger-Hekele M; Müller C; Kutilek M; Oesterreicher C; Ferenci P; Gangl A
Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):941-8. PubMed ID: 10958223
[TBL] [Abstract][Full Text] [Related]
40. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.
Fattovich G; Giustina G; Schalm SW; Hadziyannis S; Sanchez-Tapias J; Almasio P; Christensen E; Krogsgaard K; Degos F; Carneiro de Moura M
Hepatology; 1995 Jan; 21(1):77-82. PubMed ID: 7806171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
